Author: Sheena Cruickshank, Professor in Immunology, University of Manchester

T-cells, a type of immune cell, can be used to attack cancer cells. Lightspring/ Shutterstock A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own immune arsenal to fight cancer. In the trial, which […]